Since abnormal Akt activation is well documented in many human malignancies [7] and EF1α might have oncogenic effects in breast cancer [17,28], the interaction between EF1α and pAkt2 (and/or pAkt1) could represent an important mechanism for the regulation of Akt-dependent signaling pathways in cancer. This evidence concerns the gene AKT1 and breast carcinoma.